SCHEMBL30984053

SCHEMBL30984053

CC(C)(C)OC(=O)N1CCN(CCOc2ccc(-c3nc4c(OC5(C)CC5)ncnc4n3Cc3ccccc3)c(C#N)c2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NSD2 O96028 1/20 0.41
▸ SQOR Q9Y6N5 1/20 0.40
▸ RET P07949 1/20 0.39
▸ GPR4 P46093 1/20 0.39
▸ CNR1 P21554 2/20 0.37
▸ CNR2 P34972 2/20 0.37
▸ EPHX2 P34913 1/20 0.36
▸ PIK3CD O00329 4/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ AURKA O14965 1/20 0.35
▸ RPS6KB1 P23443 1/20 0.35
▸ KCNA5 P22460 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30983802 0.91 CNR1 (0.43) SQORRETGPR4CNR1CNR2
SCHEMBL30983540 0.89 RET (0.40) RETPIK3CDMAOAMAOB
SCHEMBL30983893 0.88 CNR1 (0.42) GPR4CNR1CNR2EPHX2PIK3CD
SCHEMBL30983875 0.86 CNR1 (0.41) SQORRETGPR4CNR1CNR2
SCHEMBL30983785 0.86 CNR1 (0.41) NSD2SQORRETGPR4CNR1
Hydrochloric Acid SCHEMBL30983960 0.86 LTA4H (0.38) NSD2RETPIK3CDMAOBKDM4E
SCHEMBL30983956 0.85 CNR1 (0.40) SQORGPR4CNR1CNR2EPHX2
SCHEMBL30983958 0.85 CNR1 (0.40) SQORGPR4CNR1CNR2EPHX2
SCHEMBL30983888 0.85 CNR1 (0.40) NSD2SQORRETGPR4CNR1
SCHEMBL30983948 0.85 CNR1 (0.41) SQORGPR4CNR1CNR2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback